Toronto Dominion Bank Acquires 746 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Toronto Dominion Bank grew its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 7.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,470 shares of the medical instruments supplier's stock after purchasing an additional 746 shares during the quarter. Toronto Dominion Bank owned approximately 0.05% of Mettler-Toledo International worth $14,035,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC boosted its stake in Mettler-Toledo International by 14.3% in the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock valued at $78,000 after acquiring an additional 8 shares in the last quarter. Apollon Wealth Management LLC increased its holdings in shares of Mettler-Toledo International by 2.5% in the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier's stock valued at $451,000 after acquiring an additional 9 shares during the period. Steward Partners Investment Advisory LLC raised its position in Mettler-Toledo International by 3.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock valued at $374,000 after purchasing an additional 9 shares during the last quarter. Atlantic Union Bankshares Corp boosted its stake in Mettler-Toledo International by 0.5% during the 4th quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier's stock worth $2,549,000 after purchasing an additional 10 shares during the period. Finally, 1900 Wealth Management LLC grew its position in Mettler-Toledo International by 4.9% during the 4th quarter. 1900 Wealth Management LLC now owns 257 shares of the medical instruments supplier's stock worth $314,000 after purchasing an additional 12 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Wall Street Analyst Weigh In

MTD has been the subject of several analyst reports. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective on the stock in a report on Monday, April 7th. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Finally, Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International has a consensus rating of "Hold" and an average target price of $1,302.11.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock traded down $16.85 during trading on Friday, reaching $1,156.33. The company had a trading volume of 317,154 shares, compared to its average volume of 150,874. Mettler-Toledo International Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93. The stock's 50 day moving average price is $1,094.61 and its two-hundred day moving average price is $1,206.84. The firm has a market capitalization of $24.03 billion, a price-to-earnings ratio of 28.53, a PEG ratio of 3.30 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. The business had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The business's revenue for the quarter was down 4.6% on a year-over-year basis. During the same period in the prior year, the firm posted $8.89 EPS. As a group, research analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director now directly owns 120 shares in the company, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.